Kiritsy Christopher P Insider Trades

Insider Trading History

Track insider trading activity for Kiritsy Christopher P. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Palvella Therapeutics
Palvella Therapeutics PVLA
Director
Holding Value $1.43M 12,350 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$324k 12,350 shares
$26.23
$115.42
Palvella Therapeutics
Palvella Therapeutics PVLA
Director
Holding Value $2.85M 24,700 shares
Last Trade
Dec 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$115.42
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $6.8k 500 shares
Last Trade
Dec 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.22k 500 shares
$16.43
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $544k 40,000 shares
Last Trade
Jun 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.4k 40,000 shares
$0.26
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $272k 20,000 shares
Last Trade
May 25, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$656k 10,000 shares
$65.60
$13.60
HTG Molecular Diagnostics
HTG Molecular Diagnostics HTGM
Director
Holding Value $1.92k 4,000 shares
Last Trade
Sep 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.3k 4,000 shares
$10.32
$0.48
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $544k 40,000 shares
Last Trade
Jun 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.82M 40,000 shares
$145.60
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $544k 40,000 shares
Last Trade
Jun 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.82M 40,000 shares
$145.60
$13.60
HTG Molecular Diagnostics
HTG Molecular Diagnostics HTGM
Director
Holding Value $3.84k 8,000 shares
Last Trade
Jan 27, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$282k 8,000 shares
$35.28
$0.48
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $544k 40,000 shares
Last Trade
Jun 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.8M 40,000 shares
$320.00
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $544k 40,000 shares
Last Trade
Jun 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.5M 40,000 shares
$261.60
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $544k 40,000 shares
Last Trade
Jun 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.5M 40,000 shares
$261.60
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $272k 20,000 shares
Last Trade
Jan 25, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.17M 20,000 shares
$258.40
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $272k 20,000 shares
Last Trade
Jan 25, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.38M 20,000 shares
$219.20
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $136k 10,000 shares
Last Trade
Sep 14, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2M 5,000 shares
$399.20
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $272k 20,000 shares
Last Trade
Jan 25, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.4M 20,000 shares
$617.60
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $68k 5,000 shares
Last Trade
Apr 21, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$934k 5,000 shares
$186.80
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $340k 25,000 shares
Last Trade
Apr 21, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$934k 5,000 shares
$186.80
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $272k 20,000 shares
Last Trade
Jan 25, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.22M 20,000 shares
$160.80
$13.60
Pieris Pharmaceuticals
Pieris Pharmaceuticals PIRS
Director
Holding Value $408k 30,000 shares
Last Trade
Sep 20, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.82M 30,000 shares
$127.20
$13.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up